Sodium lauryl sulfate Unknown Status Phase 1 Trials for Skin Irritation Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01821274A 21-Day Topical Safety Study of Diltiazem Hydrochloride Using a Cumulative Irritant Patch Test Design